Replimune Group, Inc. - REPL
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | Chief Financial Officer | S | D | 9,256.0 | 14.28 | 132,175.68 | 215,852.0 | View | |
| Aug 12, 2026 | Chief Executive Officer | S | D | 39,341.0 | 12.97 | 510,252.77 | 708,151.0 | View | |
| Aug 12, 2026 | Chief Financial Officer | S | D | 11,448.0 | 12.97 | 148,480.56 | 225,108.0 | View | |
| Aug 12, 2026 | Chief Medical Officer | S | D | 11,447.0 | 12.97 | 148,467.59 | 224,215.0 | View | |
| Aug 12, 2026 | Chief Accounting Officer | S | D | 7,632.0 | 12.97 | 98,987.04 | 99,425.0 | View | |
| Aug 11, 2026 | — | P | A | 2,609,946.0 | 12.0599 | 31,475,687.77 | 2,609,946.0 | View | |
| Aug 11, 2026 | — | P | A | 126,394.0 | 12.0599 | 1,524,299.0 | 126,394.0 | View | |
| Jun 03, 2026 | Chief Commercial Officer | S | D | 12,000.0 | 9.24 | 110,880.0 | 180,962.0 | View | |
| May 20, 2026 | Chief Medical Officer | S | D | 14,023.0 | 5.08 | 71,236.84 | 235,662.0 | View | |
| May 20, 2026 | Chief Accounting Officer | S | D | 7,894.0 | 5.08 | 40,101.52 | 107,057.0 | View | |
| May 20, 2026 | Chief Commercial Officer | S | D | 8,626.0 | 5.08 | 43,820.08 | 192,962.0 | View | |
| May 20, 2026 | — | S | D | 17,657.0 | 5.08 | 89,697.56 | 1,412,414.0 | View | |
| May 20, 2026 | Chief Executive Officer | S | D | 37,324.0 | 5.08 | 189,605.92 | 747,492.0 | View | |
| May 20, 2026 | Chief Financial Officer | S | D | 7,812.0 | 5.08 | 39,684.96 | 236,556.0 | View | |
| Apr 07, 2026 | — | A | A | 44,500.0 | 0.0 | 0.0 | 44,500.0 | View | |
| Apr 07, 2026 | — | A | A | 44,500.0 | 0.0 | 0.0 | 44,500.0 | View | |
| Apr 07, 2026 | Chief Commercial Officer | A | A | 75,000.0 | 0.0 | 0.0 | 75,000.0 | View | |
| Apr 07, 2026 | Chief Commercial Officer | A | A | 50,000.0 | 0.0 | 0.0 | 201,588.0 | View | |
| Apr 07, 2026 | — | A | A | 75,000.0 | 0.0 | 0.0 | 75,000.0 | View | |
| Apr 07, 2026 | — | A | A | 50,000.0 | 0.0 | 0.0 | 1,430,071.0 | View | |
| Apr 07, 2026 | — | A | A | 44,500.0 | 0.0 | 0.0 | 44,500.0 | View | |
| Apr 07, 2026 | Chief Medical Officer | A | A | 75,000.0 | 0.0 | 0.0 | 75,000.0 | View | |
| Apr 07, 2026 | Chief Medical Officer | A | A | 50,000.0 | 0.0 | 0.0 | 249,685.0 | View | |
| Apr 07, 2026 | — | A | A | 44,500.0 | 0.0 | 0.0 | 44,500.0 | View | |
| Apr 07, 2026 | Chief Accounting Officer | A | A | 55,000.0 | 0.0 | 0.0 | 55,000.0 | View | |
| Apr 07, 2026 | Chief Accounting Officer | A | D | 36,667.0 | 0.0 | 0.0 | 114,951.0 | View | |
| Apr 07, 2026 | Chief Executive Officer | A | A | 376,860.0 | 0.0 | 0.0 | 376,860.0 | View | |
| Apr 07, 2026 | Chief Executive Officer | A | A | 251,240.0 | 0.0 | 0.0 | 784,816.0 | View | |
| Apr 07, 2026 | — | A | A | 44,500.0 | 0.0 | 0.0 | 44,500.0 | View | |
| Apr 07, 2026 | — | A | A | 44,500.0 | 0.0 | 0.0 | 44,500.0 | View | |
| Apr 07, 2026 | — | A | A | 44,500.0 | 0.0 | 0.0 | 44,500.0 | View | |
| Apr 07, 2026 | — | A | A | 44,500.0 | 0.0 | 0.0 | 44,500.0 | View | |
| Apr 07, 2026 | Chief Financial Officer | A | A | 75,000.0 | 0.0 | 0.0 | 75,000.0 | View | |
| Apr 07, 2026 | Chief Financial Officer | A | A | 50,000.0 | 0.0 | 0.0 | 244,368.0 | View | |
| Apr 07, 2026 | — | A | A | 44,500.0 | 0.0 | 0.0 | 44,500.0 | View | |
| Apr 06, 2026 | Chief Commercial Officer | S | D | 6,500.0 | 8.01 | 52,065.0 | 151,588.0 | View |